NASDAQ (usa) arrow 6715.56 -12.11 -0.18%
FTSE 100 (london) arrow 7487.96 -5.12 -0.07%
DAX (german) arrow 13465.51 235.94 1.78%
NIKKEI 225 (japan) arrow 22420.08 408.47 1.86%
Hang - Seng (hong kong) arrow 28594.06 348.52 1.23%
NIFTY - 50 (india)
Straits Times (singapore) arrow 3391.61 17.53 0.52%
KOSPI (korea) arrow 2556.47 33.04 1.31%
All Ordinaries (australia) arrow 6005.30 28.90 0.48%
BOVESPA (brazil) arrow 74092.76 -215.73 -0.29%

Novo Nordisk A/S (CO: NOVO-B)

 
NOVO-B Technical Analysis
5
As on 19th Dec 2025 NOVO-B STOCK Price closed @ 310.00 and we RECOMMEND Strong Sell for LONG-TERM with Stoploss of 479.44 & Strong Sell for SHORT-TERM with Stoploss of 652.91 we also expect STOCK to react on Following IMPORTANT LEVELS.
 
 

NOVO-BSTOCK Price

Open 299.80 Change Price %
High 310.00 1 Day 5.70 1.87
Low 298.60 1 Week 0.90 0.29
Close 310.00 1 Month 18.80 6.46
Volume 15389132 1 Year -437.60 -58.53
52 Week High 790.30 | 52 Week Low 287.00
 
CO Denmark Most Active Stocks
NOVO-B 310.00 1.87%
SAS 0.01 0.00%
VWS 173.80 1.82%
CONFRZ 0.02 0.00%
DANSKE 313.50 1.42%
BIF 0.28 -3.45%
ORSTED 134.20 -0.81%
ALMB 18.15 1.06%
VJBA 7.33 0.41%
TRYG 163.70 1.61%
 
CO Denmark Top Gainers Stocks
HYDRCT 0.60 46.34%
HYPE 3.66 22.00%
DKIEEU 249.00 15.81%
SAME 1.45 10.69%
SAME 1.45 10.69%
RBLN-B 141.00 10.16%
ALEFRM 2.88 9.92%
STENO 1.42 9.23%
IMPERO 6.95 8.59%
ASTRLS 1.15 8.49%
 
CO Denmark Top Losers Stocks
LEDIBOND 0.03 -25.00%
VALUER 0.25 -21.88%
BLVIS-A 0.40 -18.37%
SHAPE 2.19 -14.12%
MONSO 0.13 -13.33%
ACT 0.72 -12.20%
ACT 0.72 -12.20%
ACT 0.72 -12.20%
ACT 0.72 -12.20%
ACT 0.72 -12.20%
 
 
NOVO-B
Daily Charts
NOVO-B
Intraday Charts
Whats New @
Bazaartrend
NOVO-B
Free Analysis
 
NOVO-B Important Levels Intraday
RESISTANCE331.97
RESISTANCE324.92
RESISTANCE320.57
RESISTANCE316.21
SUPPORT303.79
SUPPORT299.43
SUPPORT295.08
SUPPORT288.03
 
NOVO-B Forecast December 2025
4th UP Forecast527.56
3rd UP Forecast457.79
2nd UP Forecast414.66
1st UP Forecast371.53
1st DOWN Forecast248.47
2nd DOWN Forecast205.34
3rd DOWN Forecast162.21
4th DOWN Forecast92.44
 
NOVO-B Weekly Forecast
4th UP Forecast418.10
3rd UP Forecast383.43
2nd UP Forecast362.00
1st UP Forecast340.57
1st DOWN Forecast279.43
2nd DOWN Forecast258.00
3rd DOWN Forecast236.57
4th DOWN Forecast201.90
 
NOVO-B Forecast2025
4th UP Forecast1333.62
3rd UP Forecast1005.34
2nd UP Forecast802.42
1st UP Forecast599.5
1st DOWN Forecast20.5
2nd DOWN Forecast-182.42
3rd DOWN Forecast-385.34
4th DOWN Forecast-713.62
 
 
NOVO-B Other Details
Segment EQ
Market Capital 1565371138048.00
Sector Healthcare
Industry Biotechnology
Offical website >
 
NOVO-B Address
NOVO-B
 
NOVO-B Latest News
 
Your Comments and Response on Novo Nordisk A/S
 
NOVO-B Business Profile
Novo Nordisk A/S, a healthcare company, engages in the research, development, manufacture, and marketing of pharmaceutical products worldwide. It operates in two segments, Diabetes and Obesity care, and Biopharm. The Diabetes and Obesity care segment provides products in the areas of insulins, GLP-1 and related delivery systems, oral antidiabetic products, obesity, and other chronic diseases. The Biopharmaceuticals segment offers products in the areas of haemophilia, growth disorders, and hormone replacement therapy. The company collaboration agreements with Lund University to develop treatment for Parkinson's diseases; and bluebird bio, Inc. to develop genome editing treatments for children and adult patients. Novo Nordisk A/S also has a research collaboration with Lumen Bioscience, Inc. to explore strategies for delivering oral biologics for cardiometabolic disease. The company was founded in 1923 and is headquartered in Bagsvaerd, Denmark. Address: Novo Allé 1, Bagsvaerd, Denmark, 2880
 
© 2005-2023 BazaarTrend.com All rights reserved.

Data and information is provided for informational purposes only, and is not intended for trading purposes.
Neither BazaarTrend.com website nor any of its promoters shall be liable for any errors
or delays in the content, or for any actions taken in reliance thereon. Your use of this website constitutes
acceptance of our Terms Of Service